OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies ...

BAX launches five new injectible products in the United States, thus further strengthening its U.S Pharmaceuticals business ...

Desperate for cash to finance his brutal war, the Assad regime began the mass production of drugs. Fighters from Hezbollah, ...

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Long-term data from the pivotal phase 3 ELARA trial showed durable efficacy with tisagenlecleucel in high-risk follicular ...

Traditional wound care methods have limitations, highlighting the need for advanced bioactive dressings that enhance healing ...

Life-saving interventions may lead to ovarian dysfunction—casting a shadow of uncertainty over a survivor's ability to ...

which consists either of surgery and radiotherapy or of surgery and radiotherapy plus the alkylating drug Temodar/Temodal (temozolomide) from Schering-Plough in Kenilworth, New Jersey. Subjects ...

Alkylating agents are common chemotherapy medicines that help keep cancer cells from multiplying. They're used to treat different cancers, such as lung, breast, and ovarian cancers, as well as ...